08/20/2025
4:18 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
08/07/2025
6:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2025
6:05 AM | Phathom Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/24/2025
4:00 PM | Cook Anne Marie (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/24/2025
4:00 PM | Cook Anne Marie (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2025
9:47 AM | JENNISON ASSOCIATES LLC (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
06/06/2025
12:29 PM | Phathom Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SCHEDULE 13G/A | |
06/05/2025
3:54 PM | Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:55 PM | Phathom Pharmaceuticals (Issuer)
Stenhouse Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:56 PM | FIELDS HEIDI (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for PHAT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Phathom Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
06/05/2025
3:56 PM | Phathom Pharmaceuticals (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:58 PM | COLA MICHAEL F (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:58 PM | KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
3:30 PM | JENNISON ASSOCIATES LLC (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
05/23/2025
3:06 PM | Phathom Pharmaceuticals (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
4:17 PM | Breedlove Robert Charles (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
3:22 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
05/08/2025
4:27 PM | Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
6:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2025
6:05 AM | Phathom Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2025
1:30 PM | BlackRock, Inc. (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/23/2025
3:03 PM | Phathom Pharmaceuticals (Filer)
| Form DEF 14A | |
04/23/2025
3:05 PM | Phathom Pharmaceuticals (Filer)
| Form DEFA14A | |
04/16/2025
4:37 PM | Phathom Pharmaceuticals (Issuer)
Schroeder Theodore R (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/16/2025
4:44 PM | Phathom Pharmaceuticals (Issuer)
Schroeder Theodore R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2025
7:06 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2025
4:29 PM | Basta Steven L (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2025
4:30 PM | Basta Steven L (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
4:08 PM | Phathom Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/01/2025
7:17 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2025
3:46 PM | Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
3:27 PM | Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
4:18 PM | Phathom Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/06/2025
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2025
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2025
3:21 PM | Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:24 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
3:21 PM | Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
3:20 PM | Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
7:05 AM | Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Musk’s Project Colossus could mint millionaires (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the September 1st funding windo |
12/16/2024
7:05 AM | KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
10:46 AM | BlackRock, Inc. (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13G | |
11/07/2024
7:05 AM | Phathom Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
3:12 PM | Phathom Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SCHEDULE 13G/A | |
11/05/2024
2:32 PM | Phathom Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SCHEDULE 13G | |
11/04/2024
10:20 AM | JENNISON ASSOCIATES LLC (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13G | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13G | |
08/22/2024
3:05 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
Phathom Pharmaceuticals (Subject)
| Form SC 13D/A | |
MarketBeat All Access